PND109 PATIENT PREFERENCE FOR DOSING REGIMEN AND PERCEPTION OF DOSING FLEXIBILITY WITH FREMANEZUMAB FOR CHRONIC OR EPISODIC MIGRAINE: RESULTS FROM A WEB-BASED, PATIENT SURVEY FOLLOWING COMPLETION OF A 1-YEAR EXTENSION STUDY
Abstract
Authors
R.P. Cowan S.K. Gandhi B. Cloud J. Cohen D.C. Buse V. Ramirez-Campos A.H. Ahn R.B. Lipton